With More Than 100% Upside Seen In Idera Pharma Shares, Baird Initiates At Outperform
April 25, 2017 at 16:08 PM EDT
Baird initiated coverage of Idera Pharmaceuticals Inc (NASDAQ: IDRA) with an Outperform rating and a $5 price target, suggesting ...
